653 related articles for article (PubMed ID: 18204283)
1. Fatal anaphylactic sting reaction in a patient with mastocytosis.
Wagner N; Fritze D; Przybilla B; Hagedorn M; Ruëff F
Int Arch Allergy Immunol; 2008; 146(2):162-3. PubMed ID: 18204283
[TBL] [Abstract][Full Text] [Related]
2. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
Ruëff F; Wenderoth A; Przybilla B
J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
[TBL] [Abstract][Full Text] [Related]
3. Rush immunotherapy for wasp venom allergy seems safe and effective in patients with mastocytosis.
Verburg M; Oldhoff JM; Klemans RJ; Lahey-de Boer A; de Bruin-Weller MS; Röckmann H; Sanders C; Bruijnzeel-Koomen CA; Pasmans SG; Knulst AC
Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):192-6. PubMed ID: 26549336
[TBL] [Abstract][Full Text] [Related]
4. Mastocytosis and insect venom allergy.
Bonadonna P; Zanotti R; Müller U
Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):347-53. PubMed ID: 20485157
[TBL] [Abstract][Full Text] [Related]
5. Hymenoptera venom allergy.
Przybilla B; Ruëff F
J Dtsch Dermatol Ges; 2010 Feb; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
[TBL] [Abstract][Full Text] [Related]
6. Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy.
Niedoszytko M; de Monchy J; van Doormaal JJ; Jassem E; Oude Elberink JN
Allergy; 2009 Sep; 64(9):1237-45. PubMed ID: 19627278
[TBL] [Abstract][Full Text] [Related]
7. Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis.
González de Olano D; Alvarez-Twose I; Esteban-López MI; Sánchez-Muñoz L; de Durana MD; Vega A; García-Montero A; González-Mancebo E; Belver T; Herrero-Gil MD; Fernández-Rivas M; Orfao A; de la Hoz B; Castells MC; Escribano L
J Allergy Clin Immunol; 2008 Feb; 121(2):519-26. PubMed ID: 18177694
[TBL] [Abstract][Full Text] [Related]
8. [Therapy control of specific hymenoptera venom allergy].
Aust W; Wichmann G; Dietz A
Laryngorhinootologie; 2010 Dec; 89(12):725-8. PubMed ID: 21132618
[TBL] [Abstract][Full Text] [Related]
9. Outcome survey of insect venom allergic patients with venom immunotherapy in a rural population.
Roesch A; Boerzsoenyi J; Babilas P; Landthaler M; Szeimies RM
J Dtsch Dermatol Ges; 2008 Apr; 6(4):292-7. PubMed ID: 18042250
[TBL] [Abstract][Full Text] [Related]
10. Hymenoptera stings.
Fitzgerald KT; Flood AA
Clin Tech Small Anim Pract; 2006 Nov; 21(4):194-204. PubMed ID: 17265905
[TBL] [Abstract][Full Text] [Related]
11. The dilemma of the negative skin test reactors with a history of venom anaphylaxis: will this always be the case?
Bilò MB; Brianzoni F; Cinti B; Napoli G; Bonifazi F
Eur Ann Allergy Clin Immunol; 2005 Nov; 37(9):341-2. PubMed ID: 16453965
[TBL] [Abstract][Full Text] [Related]
12. [The wasp/mosquito syndrome].
Sabbah A; Hassoun S; Drouet M; Lauret MG; Doucet M
Allerg Immunol (Paris); 1999 Jun; 31(6):175-84. PubMed ID: 10443298
[TBL] [Abstract][Full Text] [Related]
13. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG
Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
[TBL] [Abstract][Full Text] [Related]
14. Fatal Anaphylaxis to Yellow Jacket Stings in Mastocytosis: Options for Identification and Treatment of At-Risk Patients.
Vos BJPR; van Anrooij B; van Doormaal JJ; Dubois AEJ; Oude Elberink JNG
J Allergy Clin Immunol Pract; 2017; 5(5):1264-1271. PubMed ID: 28499778
[TBL] [Abstract][Full Text] [Related]
15. Wasp venom is appropriate for immunotherapy of patients with allergic reaction to the European hornet sting.
Kosnik M; Korosec P; Silar M; Music E; Erzen R
Croat Med J; 2002 Feb; 43(1):25-7. PubMed ID: 11828554
[TBL] [Abstract][Full Text] [Related]
16. Serum concentration of baseline mast cell tryptase: evidence for a decline during long-term immunotherapy for Hymenoptera venom allergy.
Dugas-Breit S; Przybilla B; Dugas M; Arnold A; Pfundstein G; Küchenhoff H; Ruëff F
Clin Exp Allergy; 2010 Apr; 40(4):643-9. PubMed ID: 20100187
[TBL] [Abstract][Full Text] [Related]
17. Treatment with a combination of omalizumab and specific immunotherapy for severe anaphylaxis after a wasp sting.
Palgan K; Bartuzi Z; Gotz-Zbikowska M
Int J Immunopathol Pharmacol; 2014; 27(1):109-12. PubMed ID: 24674685
[TBL] [Abstract][Full Text] [Related]
18. Anaphylaxis after hymenoptera sting: is it venom allergy, a clonal disorder, or both?
Castells MC; Hornick JL; Akin C
J Allergy Clin Immunol Pract; 2015; 3(3):350-5. PubMed ID: 25858055
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the burden of treatment in patients receiving an EpiPen for yellow jacket anaphylaxis.
Oude Elberink JN; van der Heide S; Guyatt GH; Dubois AE
J Allergy Clin Immunol; 2006 Sep; 118(3):699-704. PubMed ID: 16950290
[TBL] [Abstract][Full Text] [Related]
20. Prevention and treatment of hymenoptera venom allergy: guidelines for clinical practice.
Bonifazi F; Jutel M; Biló BM; Birnbaum J; Muller U;
Allergy; 2005 Dec; 60(12):1459-70. PubMed ID: 16266376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
